Giving bad news to a patient is never easy. Ethicist Art Caplan discusses whether it is ever right for a physician to postpone giving bad news.

Dr Piña runs through some of the key takeaways from the ACC/AHA/HFSA Focused Update of the guidelines on the management of heart failure.

Dr Cyrus Desouza reviews GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors, offering advice on which patients may benefit from each class.

When it comes to national healthcare, 'open your eyes' to international models and 'be not afraid to change,' advises Dr George Lundberg.

For patients, knowing whether their kidney function is compromised and telling their doctor about it goes a long way toward preventing medication errors and complications.

Hospital clinicians who don't follow a patient's advance healthcare directive are at risk of being sued.

Dr Drew Ramsey reviews the recent literature on the link between nutrition and anxiety.

Reviewing recent research, Dr Jeffrey Weber concludes that an amalgam of host- and tumor-related markers will be the best indication of which patients should receive checkpoint inhibitors.

Ethicist Art Caplan discusses the moral argument about when transplantation should and shouldn't be considered in people with disabilities.

Dr Wilner and Dr Loh discuss approaches to optimizing the value of medical missions through local partnership and the organization 53rd Week.